Global drug shortages underscore the pharmaceutical industry's reliance on fragile supply chains, highlighting the urgent ...

Coriolis Pharma, a biopharma company specializing in R&D and GMP drug product development, recently announced the launch of a ...

Novo Nordisk is among global pharma leaders in the diabetes and weight loss segments. Read why I think NVO stock is a hold.

Among the drug companies contributing campaign money to U.S. Reps. Brad Schneider, Robin Kelly and Darin LaHood are several ...

Rajeev credits the company mantra of 'staying dynamic' as the reason behind its tremendous success over the years ...

Bormioli Pharma has partnered with research-focused biopharmaceutical company Chiesi for the supply of Carbon Capture ...

Blockbuster diabetes and weight loss drugs, known as GLP-1 treatments, could help reduced the rate of overdoses and ...

Belen Garijo, the CEO of Merck KGaA, says focus on growth and innovation is key to the German group’s future.

Shares of Lumos Pharma rallied after investment firm Double Point Ventures agreed to buy the biopharmaceutical company for $38 million in cash plus potential milestone payments. Lumos shares rose 12% ...

Eye drug maker Ocuphire Pharma is acquiring gene therapy developer Opus Genetics in an all-stock transaction that will see ...

Shares of Lumos Pharma were set to rise after investment firm Double Point Ventures agreed to buy the biopharmaceutical company for $38 million in cash plus potential milestone payments.

Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat GI disorders and diseases.